Y

YungShin Global Holding Corp
TWSE:3705

Watchlist Manager
YungShin Global Holding Corp
TWSE:3705
Watchlist
Price: 57.9 TWD -0.34% Market Closed
Market Cap: 15.4B TWD
Have any thoughts about
YungShin Global Holding Corp?
Write Note

YungShin Global Holding Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

YungShin Global Holding Corp
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Y
YungShin Global Holding Corp
TWSE:3705
Operating Income
NT$1.1B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
4%
Formosa Laboratories Inc
TWSE:4746
Operating Income
NT$737.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
ScinoPharm Taiwan Ltd
TWSE:1789
Operating Income
NT$442.1m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
-7%
S
SCI Pharmtech Inc
TWSE:4119
Operating Income
NT$145.3m
CAGR 3-Years
-35%
CAGR 5-Years
-26%
CAGR 10-Years
-5%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Operating Income
NT$4.5B
CAGR 3-Years
27%
CAGR 5-Years
38%
CAGR 10-Years
55%
Standard Chem & Pharm Co Ltd
TWSE:1720
Operating Income
NT$1.3B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
16%
No Stocks Found

YungShin Global Holding Corp
Glance View

Market Cap
15.4B TWD
Industry
Pharmaceuticals

YungShin Global Holding Corp. engages in resources integration and business development. The company is headquartered in Taipei City, Taipei. The company went IPO on 2011-01-03. The firm mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The firm also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.

Intrinsic Value
66.41 TWD
Undervaluation 13%
Intrinsic Value
Price
Y

See Also

What is YungShin Global Holding Corp's Operating Income?
Operating Income
1.1B TWD

Based on the financial report for Jun 30, 2024, YungShin Global Holding Corp's Operating Income amounts to 1.1B TWD.

What is YungShin Global Holding Corp's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was 53%. The average annual Operating Income growth rates for YungShin Global Holding Corp have been 7% over the past three years , 6% over the past five years , and 4% over the past ten years .

Back to Top